Loading clinical trials...
Loading clinical trials...
Clinical Validation of an Immunocytochemistry Method Using Antibody of Methionyl-tRNA Synthetase (MARS1) in the Bile Duct Cancer Cell; Multicenter Study
Conditions
Interventions
Cytology staining
Locations
5
South Korea
CHA Bundang Medical Center
Seongnam, Bundang-gu, South Korea
Gangnam Severance Hospital
Seoul, Gangnam-gu, South Korea
In Ha University Hospital
Incheon, Jung-gu, South Korea
Soon Chun Hyang University Hospital, Cheonan
Cheonan, Namdong-gu, South Korea
Pusan National University Hospital
Busan, Seo-gu, South Korea
Start Date
February 4, 2021
Primary Completion Date
February 3, 2023
Completion Date
February 3, 2023
Last Updated
March 13, 2025
Lead Sponsor
Gangnam Severance Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions